Navigation Links
Ventria's Child Health Product Recognized for Its Promise
Date:11/12/2007

SACRAMENTO, Calif., Nov. 12 /PRNewswire/ -- A review article published in the Journal of Infection entitled, "Advances in defining etiology and new therapeutic approaches in acute diarrhea" [1], recognized Ventria's Child Health Product for its benefit to children who are suffering from acute diarrhea. The review was published online and is also available in the November print version.

Ventria's product is a medical food which can be added to standard electrolyte solutions to help children get better faster. The product was designed by researchers studying the advantages of breastfeeding for children. Ventria developed a method to affordably manufacture the important nutritional components of breast milk in rice. By replenishing these nutritional components, children suffering from diarrhea recovered quicker by one and a half days compared to the current standard electrolyte product used for rehydration during diarrhea.

William Greenough III, MD, Professor of Medicine at Johns Hopkins University and a world-renowned expert in pediatric diarrhea said "I am hoping that Ventria's product might be the first improvement that would be widely added to oral hydration solutions, which are consumed by at least half of the world's children".

In the United States there are an estimated 4.5 million hospital visits for childhood diarrhea. Globally, childhood diarrhea is the second leading killer of children under the age of 5, claiming 2 million lives annually.

"Diarrheal illnesses are a major reason for children seeing their physician and a major cause of emergency room visits," said Robert Wittler, MD, Professor, Pediatric Infectious Diseases, Kansas University School of Medicine at Wichita. "Oral rehydration is a safe and effective way to treat most diarrheal illnesses and this study confirms the advantages of adding proteins contained in breast milk to oral rehydration solution. This is an important study as decreasing the duration of diarrhea lessens the likelihood of children becoming significantly dehydrated and allows children to return to daycare and school quicker and their parents who work outside the home can return to work sooner."

"Ventria has been developing this product for several years and we are pleased with the recognition from leaders in the medical community. We anticipate a successful market introduction of this product so that we can make a positive contribution to child health on a global basis." said Scott Deeter, President and CEO, Ventria Bioscience.

(1) Marcos, L, Dupont, H

Advances in defining etiology and new therapeutic approaches in acute

diarrhea.

Journal of Infection. 2007 55, 385-393

For more information, see our website at Ventria Bioscience

http://www.ventria.com

Statements in this announcement other than historical data and information constitute forward looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.


'/>"/>
SOURCE Ventria Bioscience
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Children of depressed moms do better when dad is involved, SLU researcher finds
2. High pollution linked to poor lung function growth in children in Mexico City
3. Genetic predisposition increases childhood asthma risk
4. NYC-area 1st: Morgan Stanley Childrens Hospital performs transcatheter pulmonary valve replacement
5. Obese Children Miss More School Days
6. Treating diabetes during pregnancy can break link to childhood obesity
7. Ultra-Runner to Run 63 Marathons in 63 Days for Children with Incurable Disease
8. Chinas 1-child policy could backfire on its elderly
9. Psoriasis Cure Now offers Back to School Resources for Parents of Children with Psoriasis
10. Researchers estimate about 9 percent of US children age 8 to 15 meet criteria for having ADHD
11. Majority of 2.4 Million U.S. Children With ADHD Not Diagnosed or Consistently Treated, According to New Gold Standard Study by Cincinnati Childrens Researchers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2017)... , ... June 28, 2017 , ... Anyone with a remote control has seen the ... do it, you the flipper will get rich in no time. But what about ... things can get for the buyer of a flipped house. An email recently sent ...
(Date:6/28/2017)... ... June 28, 2017 , ... David B. Sosin, a founding partner at ... over the post of 2nd Vice President for the Illinois State Bar Association , ... the ISBA’s 3rd Vice President in 2016 following a state-wide election and served in that ...
(Date:6/28/2017)... ... June 28, 2017 , ... American Farmer proudly announces the participation of Pure ... television series, scheduled to broadcast fourth quarter 2017. American Farmer airs Tuesdays at 8:30aET ... of garden pea seed. As demand grew, the small company located in Moscow, Idaho ...
(Date:6/28/2017)... ... June 28, 2017 , ... Canadian Zeolite Corp. (the “Company”) ... year study conducted by the University of Saskatchewan in partnership with PotashCorp, Agrium ... brine-impacted groundwater. As a part of the study, batch adsorption experiments were conducted ...
(Date:6/28/2017)... ... June 28, 2017 , ... Doner ... surrounding regions access to insurance assistance and financial planning services, is announcing the ... assist families in the region facing financial crisis. , Matthew 25: Ministries (M25M) ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 8, 2017  StatLab Medical Products ("StatLab" ... manufacturer of diagnostic supplies for the anatomic ... & Company LP ("Cressey & Company"), a ... growth-focused investment in the Company. Cressey & ... from selling shareholder, Prairie Capital, L.P., with ...
(Date:6/7/2017)...  Novavax, Inc., (Nasdaq: NVAX ) today announced ... of its RSV F protein recombinant nanoparticle vaccine candidate (RSV ... published in the journal Vaccine (the ... scientific conferences). The Company previously announced top line results ... the RSV F Vaccine with the goal of protecting infants ...
(Date:6/5/2017)... , June 5, 2017 The ... brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded ... Cincinnati Enquirer . Results are based on an ... in organizational health and workplace improvement. The survey measures several ... ...
Breaking Medicine Technology: